Liver Transplantation Results in Hepatocellular Carcinoma Patients With Immunosuppression Without Steroids
The purpose of this study was to evaluate the safety and efficacy of a steroid-free immunosuppression protocol in Hepatocellular Carcinoma (HCC) patients.
Immunosuppression|Hepatocellular Carcinoma|Liver Transplantation|Post-operative Complications
DRUG: solu medrol|DRUG: a steroid-free immunosuppression protocol
patient and graft survival, patient and graft survival include surviral rate and recurrence-free survival rate, Over 12-month after liver transplantation
Postoperative complications, Postoperative complications include acute rejection, infection, metabolic complications and hepatitis B-virus recurrence., Over 12-month after liver transplantation
The purpose of this study was to evaluate the safety and efficacy of a steroid-free immunosuppression protocol in Hepatocellular Carcinoma (HCC) patients.